SHANK3

SHANK3 is a gene that encodes a protein known as SH3 and multiple ankyrin repeat domains protein 3. This protein is a member of the SHANK family of proteins, which are involved in the formation and function of synapses in the brain. SHANK3 is particularly important for the development and maintenance of synaptic structures and is implicated in several neurological disorders.

Structure and Function

The SHANK3 protein is a scaffolding protein that plays a crucial role in the postsynaptic density (PSD) of excitatory synapses. It contains several domains that facilitate its interaction with other synaptic proteins, including:

• The SH3 domain, which is involved in protein-protein interactions.
• Ankyrin repeats, which are motifs that mediate protein-protein interactions.
• The PDZ domain, which binds to the C-termini of other proteins.
• The Proline-rich domain, which interacts with proteins containing SH3 domains.
• The SAM domain, which is involved in protein oligomerization.

SHANK3 acts as a scaffold that organizes other proteins at the synapse, including glutamate receptors, neuroligins, and Homer proteins. This organization is essential for synaptic signaling and plasticity.

Genetic Implications

Mutations or deletions in the SHANK3 gene are associated with several neurodevelopmental disorders, most notably Phelan-McDermid syndrome and autism spectrum disorder (ASD). These mutations can lead to a loss of function of the SHANK3 protein, resulting in impaired synaptic function and connectivity.

Phelan-McDermid Syndrome

Phelan-McDermid syndrome is a genetic disorder caused by deletions or mutations in the SHANK3 gene. It is characterized by intellectual disability, delayed or absent speech, and symptoms of autism. The loss of SHANK3 function disrupts synaptic signaling, leading to the neurological symptoms observed in this syndrome.

Autism Spectrum Disorder

SHANK3 mutations have been identified in some individuals with autism spectrum disorder. These mutations can lead to synaptic dysfunction, which is thought to contribute to the behavioral and cognitive symptoms of autism.

Research and Therapeutic Approaches

Research into SHANK3 and its role in synaptic function is ongoing. Animal models, such as SHANK3 knockout mice, are used to study the effects of SHANK3 deficiency and to test potential therapeutic interventions. Approaches being explored include:

• Gene therapy, which aims to restore normal SHANK3 function.
• Pharmacological treatments, targeting pathways affected by SHANK3 deficiency.
• Behavioral therapies, to support individuals with SHANK3-related disorders.

Also see

• Synaptic plasticity
• Neurodevelopmental disorders
• Scaffolding proteins
• Autism spectrum disorder
• Phelan-McDermid syndrome